PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Hospital • Home healthcare • Others • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Continuous product innovation • Increase in demand from homecare • Use in iron and vitamin infusions PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • B. Braun Melsungen • Baxter International • Fresenius • JW Life Science • Pfizer (Hospira) • Sippex IV bag • Other prominent vendors PART 15: APPENDIX • List of abbreviations • Exhibit 01: Parent market • Exhibit 02: Global medical specialty bags market • Exhibit 03: Market characteristics • Exhibit 04: Market segments • Exhibit 05: Market definition - Inclusions and exclusions checklist • Exhibit 06: Market size 2016 • Exhibit 07: Validation techniques employed for market sizing 2016 • Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn) • Exhibit 09: Global – Year-over-year growth 2018-2022 (%) • Exhibit 10: Five forces analysis 2017 • Exhibit 11: Five forces analysis 2022 • Exhibit 12: Bargaining power of buyers • Exhibit 13: Bargaining power of suppliers • Exhibit 14: Threat of new entrants • Exhibit 15: Threat of substitutes • Exhibit 16: Threat of rivalry • Exhibit 17: Market condition - Five forces • Exhibit 18: Market condition - Five forces 2017 • Exhibit 19: Customer landscape • Exhibit 20: End-user – Market share 2017-2022 (%) • Exhibit 21: Comparison by end-user • Exhibit 22: Hospitals – Market size and forecast 2017-2022 ($ mn) • Exhibit 23: Hospitals – Year-over-year growth 2018-2022 (%) • Exhibit 24: Countries with the most number of hospitals (2017) • Exhibit 25: Home healthcare – Market size and forecast 2017-2022 ($ mn) • Exhibit 26: Home healthcare – Year-over-year growth 2018-2022 (%) • Exhibit 27: Others – Market size and forecast 2017-2022 ($ mn) • Exhibit 28: Others – Year-over-year growth 2018-2021 (%) • Exhibit 29: Market opportunity by end-user • Exhibit 30: Global – Market share by geography 2017-2022 (%) • Exhibit 31: Regional comparison • Exhibit 32: Americas – Market size and forecast 2017-2022 ($ mn) • Exhibit 33: Rise in population aged 65 and above in US (% of total) • Exhibit 34: Americas – Year-over-year growth 2018-2022 (%) • Exhibit 35: Top three countries in Americas • Exhibit 36: EMEA – Market size and forecast 2017-2022 ($ mn) • Exhibit 37: Healthcare expenditure per capita in Germany and UK 2012-2104 ($ mn) • Exhibit 38: EMEA – Year-over-year growth 2018-2022 (%) • Exhibit 39: Top three countries in EMEA • Exhibit 40: APAC – Market size and forecast 2017-2022 ($ mn) • Exhibit 41: APAC – Year-over-year growth 2018-2022 (%) • Exhibit 42: Top three countries in APAC • Exhibit 43: Market opportunity • Exhibit 44: Rise in population aged 65 years and above (% of total) • Exhibit 45: R&D funding for three diseases 2013-2016 ($ millions) • Exhibit 46: Vendor landscape • Exhibit 47: Landscape disruption • Exhibit 48: Vendors covered • Exhibit 49: Vendor classification • Exhibit 50: Market positioning of vendors • Exhibit 51: B. Braun Melsungen – Overview • Exhibit 52: B. Braun Melsungen – Business segments • Exhibit 53: B. Braun Melsungen – Organizational developments • Exhibit 55: B. Braun Melsungen – Geographic focus • Exhibit 56: B. Braun Melsungen – Segment focus • Exhibit 57: B. Braun Melsungen – Key offerings • Exhibit 58: Baxter International overview • Exhibit 59: Baxter International – Business segments • Exhibit 60: Baxter International – Organizational developments • Exhibit 61: Baxter International – Geographic focus • Exhibit 62: Baxter International – Segment focus • Exhibit 63: Baxter – Key offerings • Exhibit 64: Fresenius overview • Exhibit 65: Fresenius – Business segments • Exhibit 66: Fresenius – Organizational developments • Exhibit 67: Fresenius – Geographic focus • Exhibit 68: Fresenius – Segment focus • Exhibit 69: Fresenius – Key offerings • Exhibit 70: JW Life Science overview • Exhibit 71: JW Life Science – Business segments • Exhibit 72: JW Life Science – Organizational developments • Exhibit 73: JW Life Science – Geographic focus • Exhibit 74: JW Life Science – Segment focus • Exhibit 75: JW Life Science – Key offerings • Exhibit 76: Pfizer overview • Exhibit 77: Pfizer – Business segments • Exhibit 78: Pfizer – Organizational developments • Exhibit 79: Pfizer – Geographic focus • Exhibit 80: Pfizer – Segment focus • Exhibit 81: Pfizer – Key offerings • Exhibit 82: Sippex IV bag overview • Exhibit 83: Sippex IV bag – Business segments • Exhibit 84: Sippex IV bag – Organizational developments • Exhibit 85: Sippex IV bag – Geographic focus • Exhibit 86: Sippex IV bag – Segment focus • Exhibit 87: Sippex IV bag – Key offerings

B. Braun Melsungen, Baxter International , Fresenius , JW Life Science, Pfizer (Hospira), Sippex IV bag